The oncogenic mechanisms of HER2, also known as receptor tyrosine protein kinase erbB-2, include promoting tumor cell proliferation, tumor angiogenesis, increasing tumor cell invasiveness, and inhibiting tumor cell apoptosis [16]. This evidence concerns the gene ERBB2 and neoplasm.